These protective effects were no longer evident in GPR109A −/− and NLRP3 −/− BMDMs, indicating that β-OHB attenuates atherosclerosis via GPR109A-NLRP3 dependent pathway. The gene discussed is NLRP3; the disease is atherosclerosis.